Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Starling

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
European Journal of Neurology|December 15, 2025
Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2-4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER TrialCristina Tassorelli, Amaal J Starling, Susanne F Awad, et al.
Bioconjugate Chemistry|July 1, 1996
Novel acid labile COL1 trityl-linked difluoronucleoside immunoconjugates: synthesis, characterization, and biological activityV F Patel, J N Hardin, J M Mastro, et al.
Molecular Cancer Therapeutics|February 2, 2013
Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenograftsSusan E Pratt, Sara Durland-Busbice, Robert L Shepard, et al.
The Journal of Biological Chemistry|June 26, 2012
Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanomaVipin Yadav, Xiaoyi Zhang, Jiangang Liu, et al.
Cancer Research|January 1, 1986
Human prostate tissue antigens defined by murine monoclonal antibodiesJ J Starling, S M Sieg, M L Beckett, et al.
Cerebral Cortex (New York, N.Y. : 1991)|April 1, 2004
NMDA receptor alterations in neurons from pediatric cortical dysplasia tissueVéronique M André, Jorge Flores-Hernández, Carlos Cepeda, et al.
Headache|December 11, 2025
Routine migraine screening as a standard of care for Women's health: A position statement from the American Headache SocietyTodd J Schwedt, Amaal J Starling, Jessica Ailani, et al.
Bioconjugate Chemistry|July 1, 1995
Site-specific prodrug activation by antibody-beta-lactamase conjugates: preclinical investigation of the efficacy and toxicity of doxorubicin delivered by antibody directed catalysisD L Meyer, K L Law, J K Payne, et al.
Headache|September 22, 2021
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headacheMichael J Marmura, Hans-Christoph Diener, Robert P Cowan, et al.
Nature Medicine|May 12, 2025
Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trialPeter J Goadsby, Jessica Ailani, David W Dodick, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
European Journal of Neurology|December 15, 2025
Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2-4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER TrialCristina Tassorelli, Amaal J Starling, Susanne F Awad, et al.
Bioconjugate Chemistry|July 1, 1996
Novel acid labile COL1 trityl-linked difluoronucleoside immunoconjugates: synthesis, characterization, and biological activityV F Patel, J N Hardin, J M Mastro, et al.
Molecular Cancer Therapeutics|February 2, 2013
Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenograftsSusan E Pratt, Sara Durland-Busbice, Robert L Shepard, et al.
The Journal of Biological Chemistry|June 26, 2012
Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanomaVipin Yadav, Xiaoyi Zhang, Jiangang Liu, et al.
Cancer Research|January 1, 1986
Human prostate tissue antigens defined by murine monoclonal antibodiesJ J Starling, S M Sieg, M L Beckett, et al.
Cerebral Cortex (New York, N.Y. : 1991)|April 1, 2004
NMDA receptor alterations in neurons from pediatric cortical dysplasia tissueVéronique M André, Jorge Flores-Hernández, Carlos Cepeda, et al.
Headache|December 11, 2025
Routine migraine screening as a standard of care for Women's health: A position statement from the American Headache SocietyTodd J Schwedt, Amaal J Starling, Jessica Ailani, et al.
Bioconjugate Chemistry|July 1, 1995
Site-specific prodrug activation by antibody-beta-lactamase conjugates: preclinical investigation of the efficacy and toxicity of doxorubicin delivered by antibody directed catalysisD L Meyer, K L Law, J K Payne, et al.
Headache|September 22, 2021
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headacheMichael J Marmura, Hans-Christoph Diener, Robert P Cowan, et al.
Nature Medicine|May 12, 2025
Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trialPeter J Goadsby, Jessica Ailani, David W Dodick, et al.
Pageof 16